DETANO and nitrated lipids increase chloride secretion across lung airway cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 39, Issue 2, 2008, Pages 150-162

  Chen, Lan ^a   Bosworth, Charles A ^a,b,d   Pico, Tristant ^a   Collawn, James F ^b,e   Varga, Karoly ^b,e   Gao, Zhiqian ^a   Clancy, John Paul ^c,e   Fortenberry, James A ^e   Lancaster Jr , Jack R ^a,b,d   Matalon, Sadis ^a,b,d,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alveolar type II cells; Calu 3 cells; Cystic fibrosis transmembrane conductance regulator; Nasal potential difference; Protein kinase G type II

Indexed keywords

1 [2 (2 AMINOETHYL) N (2 AMMONIOETHYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 (4 CHLOROPHENYLTHIO) CYCLIC GMP; 8 BROMO CYCLIC GMP; AMILORIDE; AMMONIUM DERIVATIVE; CHLORIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; GLIBENCLAMIDE; GUANYLATE CYCLASE; LINOLEIC ACID; NITRIC OXIDE; NITROLINOLEIC ACID; NITROOLEIC ACID; OLEIC ACID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SECRETION; CONTROLLED STUDY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; ION TRANSPORT; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SHORT CIRCUIT CURRENT;

ANIMALS; CELL LINE; CELL POLARITY; CHLORIDES; CYCLIC GMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GUANYLATE CYCLASE; ION TRANSPORT; LINOLEIC ACIDS; LUNG; MICE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRO COMPOUNDS; NITROSO COMPOUNDS; OLEIC ACIDS; REACTIVE NITROGEN SPECIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPIRATORY MUCOSA; THIONUCLEOTIDES;

MUS;

EID: 48649095146     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0005OC     Document Type: Article

References (52)

1. Schwiebert EM, Benos DJ, Egan ME, Stutts MJ, Guggino WB. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 1999;79:S145-S166.
2. Matalon S, O'Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu Rev Physiol 1999;61:627-661.
3. Schwiebert EM, Egan ME, Hwang TH, Fulmer SB, Allen SS, Cutting GR, Guggino WB. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 1995;81:1063-1073.
4. - channels. Biochem Biophys Res Commun 1996;218:302-308.
5. Lazrak A, Thome U, Myles C, Ware J, Chen L, Venglarik CJ, Matalon S. cAMP regulation of Cl(-) and HCO(-)(3) secretion across rat fetal distal lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L650-L658.
6. Brochiero E, Dagenais A, Prive A, Berthiaume Y, Grygorczyk R. Evidence of a functional CFTR Cl(-) channel in adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004;287:L382-L392.
7. Nielsen VG, Duvall MD, Baird MS, Matalon S. cAMP activation of chloride and fluid secretion across the rabbit alveolar epithelium. Am J Physiol 1998;275:L1127-L1133.
8. Fang X, Fukuda N, Barbry P, Sartori C, Verkman AS, Matthay MA. Novel role for CFTR in fluid absorption from the distal airspaces of the lung. J Gen Physiol 2002;119:199-208.
9. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993;9:371-377.
10. Hardiman KM, Lindsey JR, Matalon S. Lack of amiloride-sensitive transport across alveolar and respiratory epithelium of iNOS(-/-) mice in vivo. Am J Physiol Lung Cell Mol Physiol 2001;281:L722-L731.
11. Sittipunt C, Steinberg KP, Ruzinski JT, Myles C, Zhu S, Goodman RB, Hudson LD, Matalon S, Martin TR. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:503-510.
12. Zhu S, Ware LB, Geiser T, Matthay MA, Matalon S. Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001;163:166-172.
13. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-2047. [Published erratum appears in Circulation 1991;84:2212.]
14. Lang JD, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007;117:2583-2591.
15. Murad F. Shattuck Lecture: nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 2006;355:2003-2011.
16. Gaston B, Singel D, Doctor A, Stamler JS. S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 2006;173:1186-1193.
17. Zhang Y, Hogg N. The mechanism of transmembrane S-nitrosothiol transport. Proc Natl Acad Sci USA 2004;101:7891-7896.
18. Zhang Y, Hogg N. S-nitrosothiols: cellular formation and transport. Free Radic Biol Med 2005;38:831-838.
19. Lancaster JR Jr. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol 2006;19:1160-1174.
20. Zaman K, McPherson M, Vaughan J, Hunt J, Mendes F, Gaston B, Palmer LA. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation. Biochem Biophys Res Commun 2001;284:65-70.
21. Zaman K, Palmer LA, Doctor A, Hunt JF, Gaston B. Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1. Biochem J 2004;380:67-74.
22. Wang W, Oliva C, Li G, Holmgren A, Lillig CH, Kirk KL. Reversible silencing of CFTR chloride channels by glutathionylation. J Gen Physiol 2005;125:127-141.
23. - secretion in airway epithelia. J Biol Chem 2002;277:43041-43049.
24. de Jonge HR. Cyclic nucleotide-dependent phosphorylation of intestinal epithelium proteins. Nature 1976;262:591-593.
25. - channel activation. Proc Natl Acad Sci USA 1998;95:1466-1471.
26. - channel by specific protein kinases and protein phosphatases. J Biol Chem 1993;268:2037-2047.
27. Baker PR, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, Batthyany C, Sweeney S, Long MH, Iles KE, Baker LM, et al. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J Biol Chem 2005;280:42464- 42475.
28. Chen L, Patel RP, Teng X, Bosworth CA, Lancaster JR Jr, Matalon S. Mechanisms of cystic fibrosis transmembrane conductance regulator activation by s-nitrosoglutathione. J Biol Chem 2006;281:9190-9199.
29. + absorption across cultured alveolar type II monolayers. Am J Physiol 1998;274:L369-L377.
30. Schopfer FJ, Baker PR, Giles G, Chumley P, Batthyany C, Crawford J, Patel RP, Hogg N, Branchaud BP, Lancaster JR Jr, et al. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid is a hydrophobically stabilized nitric oxide donor. J Biol Chem 2005;280:19289-19297.
31. Coles B, Bloodsworth A, Clark SR, Lewis MJ, Cross AR, Freeman BA, O'Donnell VB. Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 2002;91:375-381.
32. French PJ, Bijman J, Edixhoven M, Vaandrager AB, Scholte BJ, Lohmann SM, Nairn AC, de Jonge HR. Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channels by cGMP-dependent protein kinase II. J Biol Chem 1995;270:26626-26631.
33. Prince LS, Peter K, Hatton SR, Zaliauskiene L, Cotlin LF, Clancy JP, Marchase RB, Collawn JF. Efficient endocytosis of the cystic fibrosis transmembrane conductance regulator requires a tyrosine-based signal. J Biol Chem 1999;274:3602-3609.
34. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995;6:445-455.
35. Barker PM, Gillie DJ, Schechter MS, Rubin BK. Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. Am J Respir Crit Care Med 2005;171:868-871.
36. Hardiman KM, Nicholas-Bevensee CM, Fortenberry J, Myles CT, Malik B, Eaton DC, Matalon S. Regulation of amiloride-sensitive Na(+) transport by basal nitric oxide. Am J Respir Cell Mol Biol 2004;30:720-728.
37. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, Verkman AS. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 2004;124:125-137.
38. - secretion in nasal epithelia of CF mice. Am J Physiol 1994;266:C1478-C1483.
39. Davis IC, Lazarowski ER, Hickman-Davis JM, Fortenberry JA, Chen FP, Zhao X, Sorscher E, Graves LM, Sullender WM, Matalon S. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus. Am J Respir Crit Care Med 2006;173:673-682.
40. Gaston B, Sears S, Woods J, Hunt J, Ponaman M, McMahon T, Stamler JS. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 1998;351:1317-1319.
41. - transport across the air space-capillary barrier. J Appl Physiol 2003;94:343-352.
42. Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A, Gerzer R, Minuth T, Perzborn E, Pleiss U, et al. NO-independent regulatory site on soluble guanylate cyclase. Nature 2001;410:212-215.
43. Nielsen VG, Baird MS, Chen L, Matalon S. DETANONOate, a nitric oxide donor, decreases amiloride-sensitive alveolar fluid clearance in rabbits. Am J Respir Crit Care Med 2000;161:1154-1160.
44. Jain L, Chen XJ, Brown LA, Eaton DC. Nitric oxide inhibits lung sodium transport through a cGMP-mediated inhibition of epithelial cation channels. Am J Physiol 1998;274:L475-L484.
45. Kaestle SM, Reich CA, Yin N, Habazettl H, Weimann J, Kuebler WM. Nitric oxide-dependent inhibition of alveolar fluid clearance in hydrostatic lung edema. Am J Physiol Lung Cell Mol Physiol 2007;293:L859-L869.
46. Baker PR, Schopfer FJ, Sweeney S, Freeman BA. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc Natl Acad Sci USA 2004;101:11577-11582.
47. Cole MP, Groeger AL, Schopfer FJ, Baker PRS, Iles KE, Long HM, Chumley PH, Freeman BA. Inflammatory oxidants induce fatty acid nitration in vivo [abstract]. Free Radic Biol Med 2005;39:S83.
48. Coles B, Bloodsworth A, Eiserich JP, Coffey MJ, McLoughlin RM, Giddings JC, Lewis MJ, Haslam RJ, Freeman BA, O'Donnell VB. Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J Biol Chem 2002;277:5832-5840.
49. Wright MM, Schopfer FJ, Baker PR, Vidyasagar V, Powell P, Chumley P, Iles KE, Freeman BA, Agarwal A. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc Natl Acad Sci USA 2006;103:4299-4304.
50. Batthyany C, Schopfer FJ, Baker PR, Duran R, Baker LM, Huang Y, Cervenansky C, Branchaud BP, Freeman BA. Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J Biol Chem 2006;281:20450-20463.
51. Kuebler WM, Uhlig U, Goldmann T, Schael G, Kerem A, Exner K, Martin C, Vollmer E, Uhlig S. Stretch activates nitric oxide production in pulmonary vascular endothelial cells in situ. Am J Respir Crit Care Med 2003;168:1391-1398.
52. Hickman-Davis JM, Nicholas-Bevensee C, Davis IC, Ma HP, Davis GC, Bosworth CA, Matalon S. Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection. Am J Respir Crit Care Med 2006;173:334-344.